The trial, which evaluated the safety and efficacy of brodalumab given at two doses every two weeks through subcutaneous injection compared with Stelara and placebo in these patients,
In March 2014, the company had submitted NDA for LBH589 to the FDA, and in May the agency granted priority review status to the compound, reducing the standard
The decision to terminate the trials is based on a planned safety review by the RILOMET-1 independent data monitoring committee that found an increase in the number of
rVSV-EBOV was originally developed by the Public Health Agency of Canada (PHAC) and is currently being evaluated in Phase I clinical trials. Merck Vaccines president Dr Julie Gerberding
Opdivo is BMS’s investigational PD-1 (programmed death-1) immune checkpoint inhibitor, while FPA008 is Five Prime’s monoclonal antibody that inhibits colony stimulating factor-1 receptor (CSF1R). As part of the
The company has also notified the owner of the Reference Listed Drug of its filing. In November, Endo Pharmaceuticals Solutions, Bayer Intellectual Property and Bayer Pharma filed suit
Chimerasome is based on a single protein that can be assembled to form a spherical protein nanocage encapsulating drugs or nucleic acid therapeutics. It can be decorated with
Acromegaly is a syndrome that results when the anterior pituitary gland produces excess growth hormone (GH) after epiphyseal plate closure at puberty. Novartis Oncology president Bruno Strigini said:
Duaklir is a fixed-dose combination of Eklira (aclidinium bromide), a long-acting muscarinic-antagonist (LAMA), with the long-acting beta-agonist (LABA) formoterol. Administered by the Genuair dry powder inhaler device, the
The new vaccine uses the ImuXen Technology based on the concept of simultaneous delivery of multiple active pharmaceutical ingredients (APIs) as antigens within the same liposome. The trial
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.